Home / Inspections / 1120278

FDA Inspection 1120278 — Phillip M. Pierorazio, MD

Phillip M. Pierorazio, MD — FEI 3016053302

The FDA completed an inspection of Phillip M. Pierorazio, MD on February 14, 2020 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baltimore, MD (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources